On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...

Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...

AMRX meets this criterion too, as the stock gained 10.1% over the past 12 weeks. Moreover, the momentum for AMRX is fast paced, as the stock currently has a beta of 1.23.

Amneal Pharmaceuticals Inc (AMRX) stock saw a decline, ending the day at $8.52 which represents a decrease of $-0.18 or -2.07% from the prior close of $8.7. The stock opened at $8.67 and touched a low ...

View Amneal Pharmaceuticals, Inc. (AMRX) current and estimated P/E ratio data provided by Seeking Alpha.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX – Research Report), Aura Biosciences Inc (AURA – Research Report) and Terns ...

BRIDGEWATER, N.J., September 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") and Shilpa Medicare Limited ("Shilpa") announced U.S ...

A pair of new companies are being launched to tackle high drug costs, the latest sign of employer frustration with the middlemen, known as PBMs, whose job it is to keep down the spending.

BRIDGEWATER, N.J., September 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") and Shilpa Medicare Limited ("Shilpa") announced U.S ...